International Stem Cell Corporation
International Stem Cell Corporation enters into an Agreement with Cytograft Tissue Engineering to Develop a Therapeutic Medium for Cytograft’s Living Vascular Grafts
Published in Drug Law Weekly, March 24th, 2009
International Stem Cell Corporation (OTCBB:ISCO) (www.intlstemcell.com), the first company to perfect a method of creating human “parthenogenetic” stem cells, which are derived from unfertilized human eggs, is working with tissue engineers at Cytograft Tissue Engineering, (Novato, CA), to design a custom cell culture medium to cultivate living human vascular grafts; grafts which are expected to be used in future human clinical trials.
Cytograft’s living human product, called Lifeline™ (trade-name not associated with Lifeline Cell Technology), is a promising technology that will be used as a coronary graft for coronary bypass procedures, as a peripheral graft to prevent...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-03-24)
More Articles from Drug Law Weekly
- Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley, P.C.
Anapol Schwartz Forms Consortium with Columbus, Ohio-Based Firm - Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley, P.C.
Clark, Perdue & List Co., LPA Forms Consortium with Philadelphia-Based Firm - Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley, P.C.
U.S. Supreme Court Vacates Third Circuit Decision in Anti-Depressant Suicide Case - Antares Pharma, Inc.
Antares Pharma to Host Fourth Quarter and Year-End 2008 Earnings Call - Antares Pharma, Inc.
Antares to Present at Cowen and Company 29th Annual Health Care Conference - Biologics
Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
